Details
Product Overview
-
Active Ingredients: Salmeterol Xinafoate 25 mcg and Fluticasone Propionate 125 mcg per actuation
-
Manufacturer: Glenmark Pharmaceuticals Ltd.
-
Registration Number (MAL): MAL14055154AZ
Indications
-
Management of asthma in patients aged 12 years and older
-
Treatment of chronic obstructive pulmonary disease (COPD)
-
Prevention of bronchospasm and reduction of inflammation in the airways
Instructions for Use
-
Shake the inhaler well before each use
-
Hold the inhaler upright, exhale fully, place the mouthpiece between your teeth without biting, and form a good seal with your lips
-
Breathe in slowly and deeply through your mouth while pressing down firmly on the canister to release a dose
-
Hold your breath for 5–10 seconds, then breathe out gently
-
Repeat the above steps if a second dose is prescribed
-
Replace the cover after use
-
Rinse your mouth with water after each use to reduce the risk of oral thrush
View more about Glenmark Combiwave FB 200 Inhaler - 150D on main site